Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models

被引:128
作者
Dulla, Kalyan [1 ]
Aguila, Monica [2 ]
Lane, Amelia [2 ]
Jovanovic, Katarina [2 ]
Parfitt, David A. [2 ]
Schulkens, Iris [1 ]
Chan, Hee Lam [1 ]
Schmidt, Iris [1 ]
Beumer, Wouter [1 ]
Vorthoren, Lars [1 ]
Collin, Rob W. J. [3 ]
Garanto, Alejandro [3 ]
Duijkers, Lonneke [3 ]
Brugulat-Panes, Anna [2 ]
Semo, Ma'ayan [2 ]
Vugler, Anthony A. [2 ]
Biasutto, Patricia [1 ]
Adamson, Peter [1 ,2 ]
Cheetham, Michael E. [2 ]
机构
[1] ProQR Therapeut, Zernikedreef 9, NL-2333 CK Leiden, Netherlands
[2] UCL Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England
[3] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands
基金
英国惠康基金;
关键词
LEBER CONGENITAL AMAUROSIS; ANTISENSE OLIGONUCLEOTIDES; RETINAL DEGENERATION; DISEASE MECHANISMS; PRIMARY CILIA; GENE-THERAPY; OPTIC CUPS; IN-VITRO; MUTATION; CELLS;
D O I
10.1016/j.omtn.2018.07.010
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Leber congenital amaurosis type 10 (LCA10) is a severe inherited retinal dystrophy associated with mutations in CEP290. The deep intronic c.2991 + 1655A>G mutation in CEP290 is the most common mutation in LCA10 individuals and represents an ideal target for oligonucleotide therapeutics. Here, a panel of antisense oligonucleotides was designed to correct the splicing defect associated with the mutation and screened for efficacy and safety. This identified QR-110 as the best-performing molecule. QR-110 restored wild-type CEP290 mRNA and protein expression levels in CEP290 c.2991 + 1655A>G homozygous and compound heterozygous LCA10 primary fibroblasts. Furthermore, in homozygous three-dimensional iPSC-derived retinal organoids, QR-110 showed a dose-dependent restoration of mRNA and protein function, as measured by percentage and length of photoreceptor cilia, without off-target effects. Localization studies in wild-type mice and rabbits showed that QR-110 readily reached all retinal layers, with an estimated half-life of 58 days. It was well tolerated following intravitreal injection in monkeys. In conclusion, the pharmacodynamic, pharmacokinetic, and safety properties make QR-110 a promising candidate for treating LCA10, and clinical development is currently ongoing.
引用
收藏
页码:730 / 740
页数:11
相关论文
共 50 条
[11]   Basal exon skipping and genetic pleiotropy: A predictive model of disease pathogenesis [J].
Drivas, Theodore G. ;
Wojno, Adam P. ;
Tucker, Budd A. ;
Stone, Edwin M. ;
Bennett, Jean .
SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (291)
[12]   Visual Acuity after Retinal Gene Therapy for Choroideremia [J].
Edwards, Thomas L. ;
Jolly, Jasleen K. ;
Groppe, Markus ;
Barnard, Alun R. ;
Cottriall, Charles L. ;
Tolmachova, Tanya ;
Black, Graeme C. ;
Webster, Andrew R. ;
Lotery, Andrew J. ;
Holder, Graham E. ;
Xue, Kanmin ;
Downes, Susan M. ;
Simunovic, Matthew P. ;
Seabra, Miguel C. ;
MacLaren, Robert E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (20) :1996-1998
[13]   Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy [J].
Finkel, R. S. ;
Mercuri, E. ;
Darras, B. T. ;
Connolly, A. M. ;
Kuntz, N. L. ;
Kirschner, J. ;
Chiriboga, C. A. ;
Saito, K. ;
Servais, L. ;
Tizzano, E. ;
Topaloglu, H. ;
Tulinius, M. ;
Montes, J. ;
Glanzman, A. M. ;
Bishop, K. ;
Zhong, Z. J. ;
Gheuens, S. ;
Bennett, C. F. ;
Schneider, E. ;
Farwell, W. ;
De Vivo, D. C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (18) :1723-1732
[14]   In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery [J].
Garanto, Alejandro ;
Chung, Daniel C. ;
Duijkers, Lonneke ;
Corral-Serrano, Julio C. ;
Messchaert, Muriel ;
Xiao, Ru ;
Bennett, Jean ;
Vandenberghe, Luk H. ;
Collin, Rob W. J. .
HUMAN MOLECULAR GENETICS, 2016, 25 (12) :2552-2563
[15]   Species-Dependent Splice Recognition of a Cryptic Exon Resulting from a Recurrent Intronic CEP290 Mutation that Causes Congenital Blindness [J].
Garanto, Alejandro ;
Duijkers, Lonneke ;
Collin, Rob W. J. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (03) :5285-5298
[16]   Unexpected CEP290 mRNA Splicing in a Humanized Knock-In Mouse Model for Leber Congenital Amaurosis [J].
Garanto, Alejandro ;
van Beersum, Sylvia E. C. ;
Peters, Theo A. ;
Roepman, Ronald ;
Cremers, Frans P. M. ;
Collin, Rob W. J. .
PLOS ONE, 2013, 8 (11)
[17]   Antisense Oligonucleotide Therapy for Inherited Retinal Dystrophies [J].
Gerard, Xavier ;
Garanto, Alejandro ;
Rozet, Jean-Michel ;
Collin, Rob W. J. .
RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2016, 854 :517-524
[18]   Intravitreal Injection of Splice-switching Oligonucleotides to Manipulate Splicing in Retinal Cells [J].
Gerard, Xavier ;
Perrault, Isabelle ;
Munnich, Arnold ;
Kaplan, Josseline ;
Rozet, Jean-Michel .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2015, 4 :e250
[19]   AON-mediated Exon Skipping Restores Ciliation in Fibroblasts Harboring the Common Leber Congenital Amaurosis CEP290 Mutation [J].
Gerard, Xavier ;
Perrault, Isabelle ;
Hanein, Sylvain ;
Silva, Eduardo ;
Bigot, Karine ;
Defoort-Delhemmes, Sabine ;
Rio, Marleene ;
Munnich, Arnold ;
Scherman, Daniel ;
Kaplan, Josseline ;
Kichler, Antoine ;
Rozet, Jean-Michel .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1 :e29
[20]   Pegaptanib for neovascular age-related macular degeneration [J].
Gragoudas, ES ;
Adamis, AP ;
Cunningham, ET ;
Feinsod, M ;
Guyer, DR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2805-2816